Use of serum fibroblast growth factor 23 vs. plasma B-type natriuretic peptide levels in assessing the pathophysiology of patients with heart failure
Use of serum fibroblast growth factor 23 vs. plasma B-type natriuretic peptide levels in assessing the pathophysiology of patients with heart failure
Hypertension Research 40,
181 (February 2017). doi:10.1038/hr.2016.130
Authors: Miki Imazu, Hiroyuki Takahama, Makoto Amaki, Yasuo Sugano, Takahiro Ohara, Takuya Hasegawa, Hideaki Kanzaki, Toshihisa Anzai, Naoki Mochizuki, Hiroshi Asanuma, Masanori Asakura & Masafumi Kitakaze
Source: Hypertension Research - Category: Cardiology Authors: Miki Imazu Hiroyuki Takahama Makoto Amaki Yasuo Sugano Takahiro Ohara Takuya Hasegawa Hideaki Kanzaki Toshihisa Anzai Naoki Mochizuki Hiroshi Asanuma Masanori Asakura Masafumi Kitakaze Tags: B-type natriuretic peptide cardiovascular hemodynamics fibroblast growth factor 23 left-sided heart failure right-sided heart failure Source Type: research